Loading
Anda Biopharma
Anda Biopharma integrates high-end talents and technologies in tumor genomics, immunology, and vaccinology research, and is committed to developing new personalized therapeutic vaccines for tumors
Funding
Every round, secondary, debt facility or acquisition involving Anda Biopharma that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log in